EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A Longitudinal Assessment of Anterior Cingulate Cortex Gamma-aminobutyric Acid in Antipsychotic Medication-naïve First Episode Psychosis Patients

Genelle D Samson iD, Jose O Maximo, Eric A Nelson, Nina V Kraguljac, William P Armstrong, Branden Benningfield, Seyedeh Nasim Adnani, Adil Bashir, Adrienne C Lahti

Schizophrenia Bulletin · 07.03.2026 · 52 (2)

DOI: 10.1093/schbul/sbaf079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Schizophrenia Bulletin, online erschienen am 30.06.2025. Verfasst von Genelle D Samson und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, University of Alabama at Birmingham, Birmingham, United States. Hauptthemen laut MEDLINE: Gyrus Cinguli, Psychotic Disorders, gamma-Aminobutyric Acid, Antipsychotic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIMH NIH HHS, National Institute of Mental Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Hypothesis Converging evidence from animal and human studies has implicated gamma-aminobutyric acid (GABA)-ergic dysfunction in the pathophysiology of psychosis spectrum disorders. However, little is known about GABA’s role in the early illness stages. Based on prior research, we hypothesized that GABA levels would already be altered in first episode psychosis patients (FEP), and that they would be associated with patients’ cognitive function and response to treatment. Study Design We used magnetic resonance spectroscopy with a MEGA-PRESS sequence to quantify GABA in the dorsal anterior cingulate cortex (ACC) at baseline and over the course of antipsychotic treatment with risperidone. We compared GABA levels between 79 medication-naïve FEP and 113 healthy controls (HC) longitudinally over a period of 16 weeks and examined their relationships to cognition and treatment response. Study Results We found significantly lower GABA levels in FEP compared to HC at all 3 time points (baseline, 6 weeks, 16 weeks), but did not observe a significant main effect of time or an interaction of group by time. We found no significant correlations between GABA and cognitive scores. Baseline GABA levels of patients considered treatment nonresponders significantly differed from HC, whereas responders did not. Conclusions Our findings suggest that GABA dysfunction in the ACC may be an important feature of the core pathophysiology of psychosis. This dysfunction does not appear to be attenuated by conventional antipsychotic treatment, though baseline levels may be indicative of clinical prognosis in FEP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gyrus CinguliPsychotic Disordersgamma-Aminobutyric AcidAntipsychotic AgentsRisperidoneSchizophreniaCognitive DysfunctionHumansMaleFemaleAdultLongitudinal StudiesYoung AdultMagnetic Resonance SpectroscopyAdolescent

Stichwörter der Autor:innen

GABAMEGA-PRESScognitionmagnetic resonance spectroscopyschizophreniatreatment response

Substanzen

gamma-Aminobutyric AcidAntipsychotic AgentsRisperidone

Autor:innen und Institutionen

  • Department of Psychology, University of Alabama at Birmingham, Birmingham, United States.
  • Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, United States.
  • Department of Psychiatry and Behavioral Health, Ohio State University, Columbus, United States.
  • Department of Electrical & Computer Engineering, Auburn University, Auburn, United States.

ORCID-Profile: Genelle D Samson

Förderung

  • NIMH NIH HHS
  • National Institute of Mental Health

Zitieren

APA

Samson, G. D., Maximo, J. O., Nelson, E. A., Kraguljac, N. V., Armstrong, W. P., Benningfield, B., Adnani, S. N., Bashir, A., & Lahti, A. C. (2026). A Longitudinal Assessment of Anterior Cingulate Cortex Gamma-aminobutyric Acid in Antipsychotic Medication-naïve First Episode Psychosis Patients. Schizophrenia Bulletin, 52(2). https://doi.org/10.1093/schbul/sbaf079

Vancouver

Samson GD, Maximo JO, Nelson EA, Kraguljac NV, Armstrong WP, Benningfield B, et al. A Longitudinal Assessment of Anterior Cingulate Cortex Gamma-aminobutyric Acid in Antipsychotic Medication-naïve First Episode Psychosis Patients. Schizophrenia Bulletin. 2026;52(2). doi:10.1093/schbul/sbaf079

BibTeX
@article{Samson2026,
  author = {Samson, Genelle D and Maximo, Jose O and Nelson, Eric A and Kraguljac, Nina V and Armstrong, William P and Benningfield, Branden and Adnani, Seyedeh Nasim and Bashir, Adil and Lahti, Adrienne C},
  title = {A Longitudinal Assessment of Anterior Cingulate Cortex Gamma-aminobutyric Acid in Antipsychotic Medication-naïve First Episode Psychosis Patients},
  journal = {Schizophrenia Bulletin},
  year = {2026},
  volume = {52},
  number = {2},
  doi = {10.1093/schbul/sbaf079}
}
Kostenlos starten →